Stevens-Johnson syndrome complicating adalimumab therapy in Crohn’s disease

doi:10.3748/wjg.15.4449

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3389)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

302

HTML

2916

Figures (1-3)

171

Sum=3389

Sep 21, 2009 (publication date) through Jun 17, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Sep 21, 2009; 15(35): 4449-4452
Published online Sep 21, 2009. doi: 10.3748/wjg.15.4449

Full Size Figure Download Figure

Figure 1 Mucosal lesions. A: Lip involvement with target-lesion on left upper lip progressing to a bullae (black arrow); B: Tongue desquamation demonstrated as white plaques (white arrows).

Citation: Salama M, Lawrance IC. Stevens-Johnson syndrome complicating adalimumab therapy in Crohn’s disease. World J Gastroenterol 2009; 15(35): 4449-4452
URL: https://www.wjgnet.com/1007-9327/full/v15/i35/4449.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4449